Xenix Medical Gains Clearance for Nanotechnology Designation

Xenix Medical neoWave Interbody Device

Xēnix Medical received FDA 510(k) clearance for a nanotechnology designation of its neoWave line of interbody fusion implants featuring proprietary NANOACTIV surface technology.

The nanotechnology designation enhances claims for the neoWave cervical and lumbar interbody devices with NANOACTIV surface, of which over 7,000 have been implanted in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us